Pulmonary Resection for Metastases From Colorectal Cancer
| Autor: | Tsuyoshi Yuki, Koichiro Iwanaga, Masahiro Yoshimura, Hidehito Matsuoka, Toshihiko Sakamoto, Noriaki Tsubota |
|---|---|
| Rok vydání: | 2001 |
| Předmět: |
Adult
Male Reoperation Pulmonary and Respiratory Medicine medicine.medical_specialty Lung Neoplasms Colorectal cancer medicine.medical_treatment Rectum Critical Care and Intensive Care Medicine Gastroenterology Disease-Free Survival Metastasis Pneumonectomy Carcinoembryonic antigen Internal medicine medicine Humans Survival rate Aged Retrospective Studies Aged 80 and over biology business.industry Respiratory disease Middle Aged medicine.disease Carcinoembryonic Antigen Surgery Survival Rate medicine.anatomical_structure biology.protein Female Neoplasm Recurrence Local Metastasectomy Colorectal Neoplasms Cardiology and Cardiovascular Medicine business |
| Zdroj: | Chest. 119:1069-1072 |
| ISSN: | 0012-3692 |
| DOI: | 10.1378/chest.119.4.1069 |
| Popis: | We reviewed our experience in the surgical treatment of 47 patients with colorectal pulmonary metastases and investigated factors affecting their survival.From September 1986 to December 1999, 47 patients underwent 59 thoracotomies for pulmonary metastases from colorectal cancer.The median interval between colorectal resection and lung resection (disease-free interval [DFI]) was 33 months. Overall, 5-year survival was 48%. Five-year survival was 51% for patients with solitary metastasis (n = 30), 47% for patients with ipsilateral multiple metastases (n = 11), and 50% for patients with bilateral metastases (n = 6), and there were no significant differences. Five-year survival was 80.8% for 14 patients with DFI of2 years and 39.7% for 30 patients with a DFI of2 years (p = 0.22). Five-year survival for 11 patients with normal prethoracotomy carcinoembryonic antigen (CEA) levels was 70%, and that for 26 patients with elevated prethoracotomy CEA levels (5 ng/mL) was 36% (p0.05). Eight patients had extrathoracic disease. The median survival time after pulmonary resection was 18.5 months, and the 5-year survival was 60%. A second resection for recurrent metastases was performed in five patients, and a third resection was done in one patient. All six patients are alive. The median survival of five patients who underwent a second thoracotomy was 22 months (range, 2 to 68 months), and one patient is alive 39 months after the third resection.Pulmonary resection for metastases from colorectal cancer may help prolong survival in selected patients, even with bilateral lesions, recurrent metastasectomy, or extrathoracic disease. Prethoracotomy CEA level was found to be a significant prognostic factor. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|